Laddar...
Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4
BACKGROUND: The efficacy and safety of nebulized glycopyrrolate inhalation solution (GLY), administered twice daily (BID) via the innovative eFlow(®) Closed System nebulizer (PARI Pharma GmbH, Starnberg, Germany), were demonstrated in two replicate, placebo-controlled, 12-week Phase III studies (GOL...
Sparad:
| I publikationen: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6305132/ https://ncbi.nlm.nih.gov/pubmed/30587959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S184808 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|